Wide variation seen in gluten-free food prescribing

Wide variation seen in gluten-free food prescribing

April 20 2018 Wide variation in gluten-free food (GFF) prescribing does not appear to be driven...

NPA welcomes official recognition of prescription direction to distance selling pharmacies

NPA welcomes official recognition of prescription direction to distance selling pharmacies

April 19 2018 The National Pharmacy Association has welcomed the government report which has...

GDPR advice and support for pharmacies now available from PSNC and CPS

GDPR advice and support for pharmacies now available from PSNC and CPS

April 17 2018 PSNC has posted online a 60-minute recording of its webinar on the General Data...

New tax year changes to pension costs and lost reliefs will affect small firms and locums

New tax year changes to pension costs and lost reliefs will affect small firms and locums

April 13 2018 Changes to the minimum employer contribution to pensions and a delay in National...

Scotland advises on Part 7 and Part 11 payments revisions

Scotland advises on Part 7 and Part 11 payments revisions

April 11 2018 Payment arrangements for March 2018 have been modified for pharmacy contractors in...

  • Wide variation seen in gluten-free food prescribing

    Wide variation seen in gluten-free food prescribing

    Friday, 20 April 2018 16:18
  • NPA welcomes official recognition of prescription direction to distance selling pharmacies

    NPA welcomes official recognition of prescription direction to distance selling pharmacies

    Thursday, 19 April 2018 16:41
  • GDPR advice and support for pharmacies now available from PSNC and CPS

    GDPR advice and support for pharmacies now available from PSNC and CPS

    Tuesday, 17 April 2018 08:38
  • New tax year changes to pension costs and lost reliefs will affect small firms and locums

    New tax year changes to pension costs and lost reliefs will affect small firms and locums

    Friday, 13 April 2018 15:06
  • Scotland advises on Part 7 and Part 11 payments revisions

    Scotland advises on Part 7 and Part 11 payments revisions

    Wednesday, 11 April 2018 12:54

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a pharmacy otc imageNovember 6 2017

The managing director of Celesio UK, Cormac Tobin, has left the company which includes LLoydsPharmacy and AAH Pharmaceuticals.

Mr Tobin spent more than 10 years with the Celesio group. He had “overseen three major acquisitions, introduced the UK’s first Prescription Assembly Solution (PAS) that has revolutionised off-site dispensing and embedded a ‘customer first’ culture across the workforce which now numbers around 25,000.”

Last week, Celesio UK announced that it was intending to close or sell off around 190 LloydsPharmacy stores in England as a result of pharmacy reimbursement cuts imposed by the Department of Health and NHS England.

Celesio UK is part of McKesson Europe. Brian Tyler, chairman of the management board of McKesson Europe, said: “Cormac has been an energetic and trusted leader of our UK and Ireland businesses. He has built a strong leadership team for Celesio UK and his warm and engaging personality made him many friends across community pharmacy and beyond. There is a genuine affection for him amongst our colleagues who value his ability to understand customers and patients and put them at the heart of everything we do.”

Mr Tobin has left Celesio UK with immediate effect and the remaining members of its Board will manage the business whilst a successor is sought, reporting to Brian Tyler.

Link:
Celesio UK/McKesson statement              
Today’s Pharmacist coverage of LloydsPharmacy divestment statement   

Business News

April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...
April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...